Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

New concepts in therapeutic photomedicine: photochemistry, optical targeting and the therapeutic window

Journal Article · · J. Invest. Dermatol.; (United States)
Advances in optics technology, synthetic photochemistry, and the science of photobiology make it possible to think beyond phototherapy and photochemotherapy which is dependent on direct photochemical alteration of metabolites or direct phototoxic insult to cells. This report discusses another gender of photomedicine therapy which includes in vivo photoactivation of medicines, photon-dependent drug delivery, and manipulation of host and exposure source to maximize therapeutic index. These therapeutic manipulations are made possible because the skin is highly overperfused and because non-ionizing electromagnetic radiation that enters skin and blood has adequate photon energy to cause electronic excitation. Radiation of 320-800 nm is not very directly phototoxic, is absorbed by a variety of relatively nontoxic photolabile molecules and has an internal dosimetric depth profile. This radiation can therefore be used to activate, deactivate, bind, release or biotransform medications in vivo in skin or other organs. The photochemist, synthetic chemist and photobiologist can collaborate to significantly increase therapeutic possibilities.
OSTI ID:
5704832
Journal Information:
J. Invest. Dermatol.; (United States), Journal Name: J. Invest. Dermatol.; (United States) Vol. 77:1; ISSN JIDEA
Country of Publication:
United States
Language:
English

Similar Records

Photobiology and photomedicine: the future is bright
Journal Article · Wed Jul 01 00:00:00 EDT 1981 · J. Invest. Dermatol.; (United States) · OSTI ID:5636475

Phototherapy and photochemotherapy of skin diseases
Journal Article · Wed Jul 01 00:00:00 EDT 1981 · J. Invest. Dermatol.; (United States) · OSTI ID:5638253

Laser photobiology and photomedicine
Conference · Mon Dec 31 23:00:00 EST 1984 · OSTI ID:5141655